{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T05:06:27Z","timestamp":1764997587932,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s40256-024-00643-7","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T15:02:26Z","timestamp":1712242946000},"page":"409-418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8107-5818","authenticated-orcid":false,"given":"Alexander","family":"Michel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coralie","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Ohlmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanaya","family":"Raad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederike","family":"Basedow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Haeckl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Beier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Evers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"issue":"12","key":"643_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004873","volume":"11","author":"SL Jackson","year":"2018","unstructured":"Jackson SL, Tong X, King RJ, Loustalot F, Hong Y, Ritchey MD. National burden of heart failure events in the United States, 2006 to 2014. Circ Heart Fail. 2018;11(12): e004873.","journal-title":"Circ Heart Fail"},{"issue":"11","key":"643_CR2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00392-017-1137-7","volume":"106","author":"S St\u00f6rk","year":"2017","unstructured":"St\u00f6rk S, Handrock R, Jacob J, Walker J, Calado F, Lahoz R, et al. Epidemiology of heart failure in Germany: a retrospective database study. Clin Res Cardiol. 2017;106(11):913\u201322.","journal-title":"Clin Res Cardiol"},{"issue":"8","key":"643_CR3","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","volume":"143","author":"SS Virani","year":"2021","unstructured":"Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254\u2013743.","journal-title":"Circulation"},{"issue":"1","key":"643_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","volume":"8","author":"AL Bui","year":"2011","unstructured":"Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8(1):30\u201341.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"643_CR5","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1001\/jamacardio.2020.2028","volume":"5","author":"JT Parizo","year":"2020","unstructured":"Parizo JT, Kohsaka S, Sandhu AT, Patel J, Heidenreich PA. Trends in readmission and mortality rates following heart failure hospitalization in the Veterans Affairs health care system from 2007 to 2017. JAMA Cardiol. 2020;5(9):1042\u20137.","journal-title":"JAMA Cardiol."},{"issue":"4","key":"643_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrcardio.2015.14","volume":"12","author":"SJ Greene","year":"2015","unstructured":"Greene SJ, Fonarow GC, Vaduganathan M, Khan SS, Butler J, Gheorghiade M. The vulnerable phase after hospitalization for heart failure. Nat Rev Cardiol. 2015;12(4):220\u20139.","journal-title":"Nat Rev Cardiol"},{"issue":"220","key":"643_CR7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ijcard.2016.06.080","volume":"1","author":"A Ruig\u00f3mez","year":"2016","unstructured":"Ruig\u00f3mez A, Michel A, Mart\u00edn-P\u00e9rez M, Garc\u00eda Rodr\u00edguez LA. Heart failure hospitalization: an important prognostic factor for heart failure re-admission and mortality. Int J Cardiol. 2016;1(220):855\u201361.","journal-title":"Int J Cardiol"},{"issue":"2","key":"643_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jacc.2022.04.045","volume":"80","author":"AP Ambrosy","year":"2022","unstructured":"Ambrosy AP, Parikh RV, Sung SH, Tan TC, Narayanan A, Masson R, et al. Analysis of worsening heart failure events in an integrated health care system. J Am Coll Cardiol. 2022;80(2):111\u201322.","journal-title":"J Am Coll Cardiol"},{"key":"643_CR9","doi-asserted-by":"crossref","unstructured":"Chang H-Y, Wang C-C, Wei J, Chang C-Y, Chuang Y-C, Huang C-L, et al. Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: results from TSOC-HFrEF registry. J Chin Med Assoc. 2017;80(12):750\u20137.","DOI":"10.1016\/j.jcma.2017.04.011"},{"issue":"6","key":"643_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/ejhf.2483","volume":"24","author":"D Stolfo","year":"2022","unstructured":"Stolfo D, Lund LH, Becher PM, Orsini N, Thorvaldsen T, Benson L, et al. Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata. Eur J Heart Fail. 2022;24(6):1047\u201362.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"643_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.15420\/cfr.2019.3.2","volume":"5","author":"L Papadimitriou","year":"2019","unstructured":"Papadimitriou L, Moore CK, Butler J, Long RC. The limitations of symptom-based heart failure management. Card Fail Rev. 2019;5(2):74\u20137.","journal-title":"Card Fail Rev"},{"issue":"6","key":"643_CR12","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.109.934471","volume":"122","author":"GC Fonarow","year":"2010","unstructured":"Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, et al. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010;122(6):585\u201396.","journal-title":"Circulation"},{"issue":"2","key":"643_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jchf.2021.09.004","volume":"10","author":"J Tromp","year":"2022","unstructured":"Tromp J, Ouwerkerk W, van Veldhuisen DJ, Hillege HL, Richards AM, van der Meer P, et al. A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction. JACC Heart Fail. 2022;10(2):73\u201384.","journal-title":"JACC Heart Fail."},{"issue":"1","key":"643_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/pds.3895","volume":"25","author":"F Andersohn","year":"2016","unstructured":"Andersohn F, Walker J. Characteristics and external validity of the German Health Risk Institute (HRI) database. Pharmacoepidemiol Drug Saf. 2016;25(1):106\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"643_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.puhe.2022.02.013","volume":"206","author":"M Ludwig","year":"2022","unstructured":"Ludwig M, Enders D, Basedow F, Walker J, Jacob J. Sampling strategy, characteristics and representativeness of the InGef research database. Public Health. 2022;206:57\u201362.","journal-title":"Public Health"},{"issue":"8","key":"643_CR16","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jacc.2018.11.049","volume":"73","author":"J Butler","year":"2019","unstructured":"Butler J, Yang M, Manzi MA, Hess GP, Patel MJ, Rhodes T, et al. Clinical course of patients with worsening heart failure with reduced ejection fraction. J Am Coll Cardiol. 2019;73(8):935\u201344.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"643_CR17","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cardfail.2022.04.015","volume":"28","author":"N Sepehrvand","year":"2022","unstructured":"Sepehrvand N, Islam S, Dover DC, Kaul P, McAlister FA, Armstrong PW, et al. Epidemiology of worsening heart failure in a population-based cohort from Alberta, Canada: evaluating eligibility for treatment with vericiguat. J Card Fail. 2022;28(8):1298\u2013308.","journal-title":"J Card Fail"},{"key":"643_CR18","doi-asserted-by":"crossref","unstructured":"El Hadidi S, Vaughan C, Kerins D, Byrne S, Darweesh E, Bermingham M. Guideline-led prescribing to ambulatory heart failure patients in a cardiology outpatient service. Int J Clin Pharm. 2021;43(4):1082\u20139.","DOI":"10.1007\/s11096-020-01220-z"},{"key":"643_CR19","doi-asserted-by":"crossref","unstructured":"Soh BWT, Langille J, O\u2019Brien K, Glasgow J, Murray S, Abbas S, et al. The increasing complexity of guideline-directed medical therapy for heart failure with reduced ejection fraction and challenges for real-world implementation. SN Comp Clin Med. 2023;5(1):200.","DOI":"10.1007\/s42399-023-01530-z"},{"issue":"4","key":"643_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250298","volume":"16","author":"C Ruff","year":"2021","unstructured":"Ruff C, Gerharz A, Groll A, Stoll F, Wirbka L, Haefeli WE, et al. Disease-dependent variations in the timing and causes of readmissions in Germany: a claims data analysis for six different conditions. PLoS ONE. 2021;16(4): e0250298.","journal-title":"PLoS ONE"},{"issue":"6","key":"643_CR21","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00392-018-1210-x","volume":"107","author":"O Riedel","year":"2018","unstructured":"Riedel O, Ohlmeier C, Enders D, Els\u00e4sser A, Vizcaya D, Michel A, et al. The contribution of comorbidities to mortality in hospitalized patients with heart failure. Clin Res Cardiol. 2018;107(6):487\u201397.","journal-title":"Clin Res Cardiol"},{"issue":"12","key":"643_CR22","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/ejhf.813","volume":"19","author":"O Chioncel","year":"2017","unstructured":"Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19(12):1574\u201385.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"643_CR23","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/ejhf.1857","volume":"22","author":"M Packer","year":"2020","unstructured":"Packer M, Metra M. Guideline-directed medical therapy for heart failure does not exist: a non-judgmental framework for describing the level of adherence to evidence-based drug treatments for patients with a reduced ejection fraction. Eur J Heart Fail. 2020;22(10):1759\u201367.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"643_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/ehjcvp\/pvaa108","volume":"8","author":"S El Hadidi","year":"2022","unstructured":"El Hadidi S, Rosano G, Tamargo J, Agewall S, Drexel H, Kaski JC, et al. Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing. Eur Heart J Cardiovas Pharmacother. 2022;8(2):187\u2013210.","journal-title":"Eur Heart J Cardiovas Pharmacother."},{"issue":"9","key":"643_CR25","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1002\/ejhf.2271","volume":"23","author":"G Savarese","year":"2021","unstructured":"Savarese G, Bodegard J, Norhammar A, Sartipy P, Thuresson M, Cowie MR, et al. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden). Eur J Heart Fail. 2021;23(9):1499\u2013511.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"643_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2022.08.009","volume":"11","author":"G Savarese","year":"2023","unstructured":"Savarese G, Kishi T, Vardeny O, Adamsson Eryd S, Bodeg\u00e5rd J, Lund LH, et al. Heart failure drug treatment-inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF). JACC Heart Fail. 2023;11(1):1\u201314.","journal-title":"JACC Heart Fail."},{"issue":"2","key":"643_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11606-017-4199-3","volume":"33","author":"EL McQuaid","year":"2018","unstructured":"McQuaid EL, Landier W. Cultural issues in medication adherence: disparities and directions. J Gen Intern Med. 2018;33(2):200\u20136.","journal-title":"J Gen Intern Med"},{"issue":"14","key":"643_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022164","volume":"10","author":"SY Wang","year":"2021","unstructured":"Wang SY, Valero-Elizondo J, Ali HJ, Pandey A, Cainzos-Achirica M, Krumholz HM, et al. Out-of-pocket annual health expenditures and financial toxicity from healthcare costs in patients with heart failure in the United States. J Am Heart Assoc. 2021;10(14): e022164.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"643_CR29","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s11606-007-0180-x","volume":"22","author":"BA Briesacher","year":"2007","unstructured":"Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22(6):864\u201371.","journal-title":"J Gen Intern Med"},{"key":"643_CR30","unstructured":"OPTUM. Retrospective database analysis. https:\/\/www.optum.com\/content\/dam\/optum\/resources\/productSheets\/Retrospective-Database-Analysis.pdf. Accessed 29 Feb 2024."}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00643-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40256-024-00643-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-024-00643-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T11:12:54Z","timestamp":1715685174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40256-024-00643-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,4]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["643"],"URL":"https:\/\/doi.org\/10.1007\/s40256-024-00643-7","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"type":"print","value":"1175-3277"},{"type":"electronic","value":"1179-187X"}],"subject":[],"published":{"date-parts":[[2024,4,4]]},"assertion":[{"value":"19 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Alexander Michel, Christoph Ohlmeier, and Thomas Evers are employees of Bayer. Coralie Lecomte is an employee of Aetion, Inc. and holds stock options of Aetion, Inc. Hanaya Raad was an employee of Aetion Inc. at the time of the study and holds stock options of Aetion Inc. Dennis H\u00e4ckl is an employee of WIG2 GmbH, which has received funding from Bayer AG. Frederike Basedow and Dominik Beier are employed by InGef, which acted as a subcontractor and received funding from WIG2 for the execution of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study was funded by Bayer AG (grant number, not applicable).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"This was a retrospective study using de-identified administrative data that received waiver of authorization for use and disclosure of protected health information from US WIRB-Copernicus Group institutional review board on 1 December 2021. No additional approval was required for use of the InGef database due to the data being anonymized.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/publish"}},{"value":"Study concept: A Michel, C Ohlmeier, T Evers. Study design: A Michel, C Lecomte, C Ohlmeier. Analysis of data: H Raad, F Basedow, D Beier. Interpretation of data: A Michel, C Lecomte, C Ohlmeier, D H\u00e4ckl, D Beier. Writing the first manuscript draft: A Michel. Review of subsequent manuscript drafts: all authors. Approval of the final version for publication: all authors.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Aggregated data are available from the corresponding author upon reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data, material and code availability"}}]}}